Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues
Product revenue, net	$ 105,650,000	$ 87,149,000
Collaboration revenue	837,000	0
Total revenues	106,487,000	87,149,000
Expenses
Cost of product revenue	(38,452,000)	(33,619,000)
Cost of collaboration revenue	(195,000)	0
Research and development	(60,729,000)	(54,645,000)
Selling, general, and administrative	(63,422,000)	(69,194,000)
Loss from operations	(56,311,000)	(70,309,000)
Interest income	8,606,000	9,658,000
Interest expenses	(1,187,000)	(113,000)
Foreign currency gains (losses)	651,000	(2,068,000)
Other (expense) income, net	(197,000)	9,361,000
Loss before income tax	(48,438,000)	(53,471,000)
Income tax expense	0	0
Net loss	$ (48,438,000)	$ (53,471,000)
Loss per share - basic (in dollars per share)	$ (0.04)	$ (0.05)
Loss per share - diluted (in dollars per share)	$ (0.04)	$ (0.05)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares)	1,080,825,300	973,145,760
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares)	1,080,825,300	973,145,760